TD Asset Management Inc. Has $4.47 Million Stake in Smith & Nephew SNATS, Inc. (SNN)

TD Asset Management Inc. grew its stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) by 286.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 121,710 shares of the medical equipment provider’s stock after purchasing an additional 90,236 shares during the period. TD Asset Management Inc.’s holdings in Smith & Nephew SNATS were worth $4,468,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Bahl & Gaynor Inc. lifted its holdings in shares of Smith & Nephew SNATS by 0.3% during the second quarter. Bahl & Gaynor Inc. now owns 21,440 shares of the medical equipment provider’s stock valued at $645,000 after purchasing an additional 60 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Smith & Nephew SNATS by 0.9% during the second quarter. The Manufacturers Life Insurance Company now owns 7,437 shares of the medical equipment provider’s stock valued at $260,000 after purchasing an additional 63 shares during the last quarter. Wrapmanager Inc. lifted its holdings in shares of Smith & Nephew SNATS by 2.1% during the second quarter. Wrapmanager Inc. now owns 10,178 shares of the medical equipment provider’s stock valued at $355,000 after purchasing an additional 207 shares during the last quarter. Wetherby Asset Management Inc. lifted its holdings in shares of Smith & Nephew SNATS by 2.6% during the second quarter. Wetherby Asset Management Inc. now owns 16,415 shares of the medical equipment provider’s stock valued at $572,000 after purchasing an additional 415 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd lifted its holdings in shares of Smith & Nephew SNATS by 5.8% during the second quarter. Dynamic Technology Lab Private Ltd now owns 7,694 shares of the medical equipment provider’s stock valued at $268,000 after purchasing an additional 424 shares during the last quarter. 6.63% of the stock is owned by institutional investors and hedge funds.

Several brokerages have recently commented on SNN. Canaccord Genuity began coverage on Smith & Nephew SNATS in a report on Wednesday, October 11th. They set a “buy” rating and a $42.00 target price for the company. Zacks Investment Research downgraded Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a report on Tuesday, September 19th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $42.50.

Shares of Smith & Nephew SNATS, Inc. (NYSE SNN) traded up $0.04 during trading on Thursday, reaching $35.95. The company had a trading volume of 276,700 shares, compared to its average volume of 494,509. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.18 and a quick ratio of 1.08. Smith & Nephew SNATS, Inc. has a 1 year low of $28.45 and a 1 year high of $40.43.

TRADEMARK VIOLATION WARNING: “TD Asset Management Inc. Has $4.47 Million Stake in Smith & Nephew SNATS, Inc. (SNN)” was first reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.thelincolnianonline.com/2017/12/07/td-asset-management-inc-has-4-47-million-stake-in-smith-nephew-snats-inc-snn.html.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply